epacadostat

Keytruda Opdivo

Pharma

2018 is here. Now get ready for ‘market-defining’ I-O readouts

If you thought 2017 was a game-changer for immuno-oncology, just wait.

Carly Helfand Jan 2, 2018 11:47am

Keytruda

Merck, Incyte IO combo fends off melanoma for 12 months-plus

Sep 9, 2017 9:59am

ASCO

BMS loses more ground to Merck as ASCO data stacks up

Jun 7, 2017 12:14pm

Opdivo

Merck, BMS racing again with new Incyte combos

Apr 3, 2017 9:07am